Resverlogix Corp.

TSX Exchange | Aug 14, 2020, 3:51 AM EDT | Real-time price

RVX $ 0.78 RT
0.01 (1.2987%)
Day Low: 0.78
Day High: 0.80
Detailed Quote
Open: 0.79
High: 0.80
Beta: 0.4872
Listed Shares Out.1: 213,090,221
Total Shares (All Classes)2: 210,716,454
Prev. Close: 0.77
Low: 0.78
VWAP: 0.7944
Market Cap1: 166,210,372
Market Cap (All Classes)2*: 164,358,834
Dividend: N/A
Div. Frequency: N/A
P/E Ratio: 3.20
EPS: 0.24
Yield: N/A
Ex-Div Date: N/A
P/B Ratio: -0.634
Exchange: TSX

(1) Number based only on listed classes of shares.

(2) Number sourced from third party data provider. For the most up to date information, please refer to the company's financial documents.

*Market Capitalization is based on Total Shares Outstanding for all share classes for the company. Convertible bonds and employee stock options that would otherwise be included in the Diluted Shares amount included in a company's filings/financials are not included.


Resverlogix Corp clinical-stage biotechnology company. The company is developing an advanced epigenetic drug called apabetalone for the treatment of patients with cardiovascular disease, diabetes mellitus, chronic kidney disease, peripheral artery disease, orphan diseases, and neurodegenerative diseases. More

News Headlines for Resverlogix Corp.
News Headlines for Resverlogix Corp.
Last 25 Trades
Copyright © QuoteMedia. Data delayed 15 minutes unless otherwise indicated. View delay times for all exchanges. Market Data powered by QuoteMedia, Fundamentals by Morningstar. See the QuoteMedia Terms of Use.